PUBLISHED DATE : Nov 2020 | Pages : 274
Fill out your details & get your free sample
Rapid Diagnostics Market Size, Share, Trends Analysis Report by End-users (Hospitals & Clinics, Laboratories, Individuals/Homecare Healthcare Settings, and Others), Products (Consumables and Analyzers/Instruments), Prescription (Professional Diagnostics and Home/OTC based Testing), Application (Blood Glucose Testing, Cardiometabolic Testing, Infectious Disease Testing, Blood Coagulation Testing, Hematology Testing, Cancer Testing, Drug Abuse Testing, and Pregnancy & Fertility/Ovulation Testing), and Geography (APAC, North America, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025
274 Pages
61 Tables
128 Charts
5 Regions
18 Countries
45 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 43 BILLION (2025) |
| CAGR | 10% (2020-2025) |
| Base Year | 2019 |
| Forecast Year | 2020-2025 |
| Market Segments | End-users (Hospitals & Clinics, Laboratories, Individuals/Homecare Healthcare Settings and Others), Products (Consumables and Analyzers/Instruments), Prescription (Professional Diagnostics and Home/OTC based Testing), Application (Blood Glucose Testing, Cardiometabolic Testing, Infectious Disease Testing, Blood Coagulation Testing, Hematology Testing, Cancer Testing, Drug Abuse Testing, and Pregnancy & Fertility/Ovulation Testing) |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, Turkey, South Africa, and Saudi Arabia |
The global rapid diagnostics market size to cross USD 43 billion by 2025, growing at a CAGR of 10% during 2020-2025. The global rapid diagnostics market is one of the major segments of the global in-vitro diagnostics market. The segment has experienced unprecedented growth after the outbreak of the novel coronavirus. The pandemic, which was initially identified in Wuhan, Hubei Province, China, in December 2019, infected over 35.7 million people, resulting in approximately 1.05 million deaths across the globe till the end of September 2020. In response to the growing COVID-19 pandemic and the shortage of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling rapid and easy-to-use devices to facilitate testing outside of laboratory settings. These simple test kits are based either on the detection of proteins from the COVID-19 virus in respiratory samples (e.g., sputum, throat swab) or the detection in blood or serum of human antibodies generated in response to the infection.
This research report includes a detailed segmentation by
In 2019, the blood glucose testing segment accounted for over 61% of the rapid diagnostics market. Point of care testing (POCT) for glucose levels is a common procedure performed several times a day in different medical settings worldwide. POCT glucose devices deliver rapid and relatively precise glucose measurements performed on the blood at patients’ bedsides, thereby offering quick results. New technology is constantly being introduced. Implantable sensor devices for continuous glucose monitoring that last three to seven days have been approved by the FDA and allow for strict glycemic controls with less discomfort for the patient.
The rapid cardiometabolic testing segment constituted a share of over 11% of the global market. The prevalence of chronic cardiovascular and metabolic diseases is increasing across the globe. Cardiovascular diseases (CVDs) are a major cause of death across the globe. An estimated 17.9 million deaths take place annually due to CVDs. Moreover, the prevalence of cardiovascular diseases is increasing due to lifestyle changes and an increase in diabetes, hypertension, obesity/overweight among young and elderly groups. Hence, the rise in cardiovascular and lifestyle diseases is expected to affect the market positively.
Rapid infectious disease tests are critical for early disease detection for improving global health. Advances in diagnostics could improve clinical management of a range of diseases in the healthcare system. The ability to rapidly diagnose infectious disease has been identified as a strategic priority by several institutes, thereby increasing the infectious disease diagnostic market's growth.
In 2019, the consumables segment accounted for a share of over 73%. The increasing share can be attributed to the high usage of a wide array of standard reagents and test kits to perform several tests. The usage of consumables is reoccurring in nature; the consumables segment generates continuous revenue for vendors. Therefore, several renowned vendors are manufacturing consumables required for analyzers.
The instruments/analyzers segment is growing at a slower pace than the consumables segment. The purchase of instruments/analyzers requires large investments and budget allocations. However, the usage of POC instruments is increasing slowly. An increase in the prevalence of several acute and chronic diseases such as cardiovascular diseases, hepatitis, HIV, cancer, chronic kidney disease, diabetes, and sexually transmitted diseases (STDs) contributes majorly toward the growing demand for rapid test kits POC analyzers.
The blood glucose testing segment is growing at a significant rate. The growth can be attributed to the growing demand for compact and portable benchtop analyzers, handheld analyzers, and professional rapid test kits for diagnosing various acute and chronic diseases in low-resource and ambulatory care settings. Professional healthcare settings, such as physician office labs, clinics, emergency care centers, critical care in hospitals, nursing homes, community care centers, home care centers such as geriatric and pediatric care centers are performing a broad range of POC diagnostic tests for quick diagnosis and deciding on prescribing the appropriate treatment for patients.
The trend of self-testing is slowly growing across developing countries, especially for blood glucose, pregnancy and ovulation, and blood coagulation testing. This trend is in the mature stage in developed countries. The prevalence of chronic diseases and infectious diseases is increasing across the globe. The demand for several at-home tests increases at a steady pace as people have shifted their focus toward home-based healthcare services due to convenience and cost-effectiveness. Self-testing and screening kits continue to garner widespread attention and recognition from major key stakeholders.
In 2019, the home care segment accounted for 51% of the global rapid diagnostic testing market. Home care settings have become popular, and the demand for these settings has been growing globally. The demand is extremely high in developed countries. Several factors, such as changes in demography and epidemiology, have affected the popularity of home settings. A rise in communicable/contagious diseases such as the COVID-19 virus has influenced the demand for home care setting and rapid diagnostics tests for COVID-19. Several lifestyle-related diseases such as diabetes, heart and respiratory diseases, stroke, and cancer could be effectively and efficiently taken care of at home with appropriate support. Moreover, changes in social norms, values, and behavior contribute to the increasing demand for formal home care services.
The hospital's end-user segment accounted for the share of 25% in 2019 due to the high volume of infectious disease diagnosis being performed in this setting. Also, hospitals' market dominance end-user segment is due to an increase in the number of private hospitals that have their own central laboratories performing a huge volume of rapid tests.
The number of private and public laboratories is growing in major cities worldwide due to an increase in epidemic conditions and the increased prevalence of infectious diseases such as malaria, dengue, and HIV. Therefore, the demand for diagnosis testing plays an important role in preventing the spread of acute diseases and making important clinical decisions regarding treatment regimens.
North America accounted for a major share of over 38% in the global rapid diagnostics market. The growing pool of patient population with several infectious diseases such as hepatitis, TB, and HIV is expected to drive the market growth. There is an increase in the prevalence of various diseases in North America, especially STDs and COVID-19. The outbreak of Ebola and Zika viruses has been among several infectious diseases that have caught the attention of diagnostic testing developers. The COVID-19 virus has affected the US adversely and has increased rapid testing to prevent and spread in the US. The US has conducted the highest number of COVID-19 tests in the world. It conducted more than 87 million tests to prevent the spread of the disease. In March 2020, the US FDA authorized an emergency use authorization of the first point-of-care rapid test to detect the virus.
The global rapid disease diagnostics market is highly dynamic, with several global and local players offering a diverse range of instruments/analyzers and reagents for diagnosing infectious and other diseases. The market is consolidated with global players accounting for dominant shares. Abbott, BD, Danaher, F. Hoffmann-La Roche, Luminex, Quidel, and Thermo Fisher Scientific are the leading players that account for significant shares in the rapid diagnostics market. Global players focus on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio. Abbott, F. Hoffmann-La Roche, Danaher, Quidel, Luminex, and BD are continuously focusing on product development and offering new diagnostics technology to increase their market presence.
By Application
By Products
By End-user
By Geography
Frequently Asked Questions
What is the rapid diagnostics market size and growth rate during the forecast period?
The rapid diagnostics market size to reach over USD 43 billion by 2025, growing at a CAGR of close to 10% during the forecast period.
What are the factors affecting the growth of the rapid diagnostics market share?
The outbreak of the COVID-19 pandemic and the growing prevalence of several acute and chronic diseases are expected to drive the market.
What is the growth of APAC rapid diagnostics market share during the forecast period?
The APAC rapid diagnostics market is expected to observe an incremental growth of over USD 5 billion by 2025.
Who are the leading vendors in the rapid diagnostics market?
Abbott, F.Hoffman-La Roche, and Siemens Healthineers are the key players in the rapid diagnostics market.
The rapid diagnostics market by revenue is expected to grow at a CAGR of 10% during the period 2019–2025.
The following factors are likely to contribute to the growth of the rapid diagnostics market during the forecast period:
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the rapid diagnostics market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Prominent Vendors
Other Prominent Vendors
Upcoming Companies
By Application
By Products
By End-user
By Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Application
4.4.3 Market Segmentation by Prescription
4.4.4 Market Segmentation by End-Users
4.4.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Economic Benefits of Rapid Diagnostic Testing
8 Market Opportunities & Trends
8.1 Increase In Demand For Rapid Tests Due To Covid-19
8.2 Growing Demand For Rapid Molecular Diagnostic Tests
8.3 New Rapid Diagnostics’ Approvals/Launches
9 Market Growth Enablers
9.1 Increase In Prevalence/Incidence Of Several Acute And Chronic Diseases
9.2 Preference For Early Diagnosis & Disease Prevention
9.3 Focus on Innovative Rapid Diagnostic Platforms
10 Market Restraints
10.1 Stringent Regulations Coupled With Product Recalls
10.2 Limitations And Data Accuracy Challenges With Rapid Diagnostics
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Instruments/Analyzers
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Blood Glucose Testing
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Rapid Cardiometabolic Testing
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 Rapid Infectious Disease Testing
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.6 Rapid Blood Coagulation Testing
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.7 Rapid Hematology Testing
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.8 Rapid Cancer Testing
13.8.1 Market Overview
13.8.2 Market Size & Forecast
13.9 Rapid Drugs Of Abuse Testing
13.9.1 Market Overview
13.9.2 Market Size & Forecast
13.10 Pregnancy And Fertility/Ovulation Testing
13.10.1 Market Overview
13.10.2 Market Size & Forecast
14 Prescription
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Professional POC Diagnostics
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 AT-HOME/OTC-BASED Rapid Diagnostics
14.4.1 Market Overview
14.4.2 Market Size & Forecast
15 End-Users
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Hospitals And Clinics
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Laboratories
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Home Care
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Others
15.6.1 Market Overview
15.6.2 Market Size & Forecast
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 US: Market Size & Forecast
17.3.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 France: Market Size & Forecast
18.3.3 UK: Market Size & Forecast
18.3.4 Italy: Market Size & Forecast
18.3.5 Spain: Market Size & Forecast
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 China: Market Size & Forecast
19.3.2 Japan: Market Size & Forecast
19.3.3 Australia: Market Size & Forecast
19.3.4 South Korea: Market Size & Forecast
19.3.5 India: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Brazil: Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast
21 Middle East And Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.3 KEY COUNTRIES
21.3.1 Turkey: Market Size & Forecast
21.3.2 South Africa: Market Size & Forecast
21.3.3 Saudi Arabia: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Abbott
22.2.2 Siemens Healthineers
22.2.3 BD
22.2.4 Quidel
22.2.5 Danaher
22.2.6 F. Hoffmann-La Roche
22.2.7 LifeScan
22.2.8 Ascensia Diabetes Care Holdings
23 Key Company Profiles
23.1 Abbott
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 F. Hoffmann-La Roche
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Siemens Helathineers
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
24 Key Companies To Watch
24.1 Ascensia Diabetes Care Holdings
24.1.1 Business Overview
24.1.2 Product Offerings
24.1.3 Key Strategies
24.1.4 Key Strengths
24.1.5 Key Opportunities
24.2 LifeScan
24.2.1 Business Overview
24.2.2 Product Offerings
24.2.3 Key Strategies
24.2.4 Key Strengths
24.2.5 Key Opportunities
24.3 BD
24.3.1 Business Overview
24.3.2 Product Offerings
24.3.3 Key Strategies
24.3.4 Key Strengths
24.3.5 Key Opportunities
24.4 QUIDEL
24.4.1 Business Overview
24.4.2 Product Offerings
24.4.3 Key Strategies
24.4.4 Key Strengths
24.4.5 Key Opportunities
24.5 Danaher
24.5.1 Business Overview
24.5.2 Product Offerings
24.5.3 Key Strategies
24.5.4 Key Strengths
24.5.5 Key Opportunities
25 Other Prominent Vendors
25.1 Abaxis
25.1.1 Business Overview
25.1.2 Product Offerings
25.2 Abingdon Health
25.2.1 Business Overview
25.2.2 Product Offerings
25.3 ACON Laboratories
25.3.1 Business Overview
25.3.2 Product Offerings
25.4 AgaMatrix
25.4.1 Business Overview
25.4.2 Product Offerings
25.5 Arbor Vita
25.5.1 Business Overview
25.5.2 Product Offerings
25.6 Assure Tech
25.6.1 Business Overview
25.6.2 Product Offerings
25.7 Autobio
25.7.1 Business Overview
25.7.2 Product Offerings
25.8 Beijing Wantai BioPharm
25.8.1 Business Overview
25.8.2 Product Offerings
25.9 BioMedomics
25.9.1 Business Overview
25.9.2 Product Offerings
25.10 Biomerica
25.10.1 Business Overview
25.10.2 Product Offerings
25.11 bioMérieux
25.11.1 Business Overview
25.11.2 Product Offerings
25.12 Biopanda Reagents
25.12.1 Business Overview
25.12.2 Product Offerings
25.13 Chembio Diagnostic Systems
25.13.1 Business Overview
25.13.2 Product Offerings
25.14 Cellex
25.14.1 Business Overview
25.14.2 Product Offerings
25.15 Clinical Reference Laboratory
25.15.1 Business Overview
25.15.2 Product Offerings
25.16 CTK Biotech
25.16.1 Business Overview
25.16.2 Product Offerings
25.17 EKF Diagnostics
25.17.1 Business Overview
25.17.2 Product Offerings
25.18 Exact Sciences
25.18.1 Business Overview
25.19 Hangzhou AllTest Biotech
25.19.1 Business Overview
25.19.2 Product Offerings
25.20 Hangzhou Biotest Biotech
25.20.1 Business Overview
25.20.2 Product Offerings
25.21 Healgen Scientific
25.21.1 Business Overview
25.21.2 Product Offerings
25.22 Instrumentation Laboratory
25.22.1 Business Overview
25.22.2 Product Offerings
25.23 Megna Health
25.23.1 Business Overview
25.23.2 Product Offerings
25.24 Meridian Bioscience
25.24.1 Business Overview
25.24.2 Product Offerings
25.25 MP Biomedicals
25.25.1 Business Overview
25.25.2 Product Offerings
25.26 NOWDiagnostics
25.26.1 Business Overview
25.26.2 Product Offerings
25.27 Salofa Oy
25.27.1 Business Overview
25.27.2 Product Offerings
25.28 Sekisui Diagnostics
25.28.1 Business Overview
25.29 SEASUN BIOMATERIALS
25.29.1 Business Overview
25.29.2 Product Offerings
25.30 Sinocare
25.30.1 Business Overview
25.30.2 Product Offerings
25.31 SureScreen Diagnostics
25.31.1 Business Overview
25.31.2 Product Offerings
25.32 Sysmex
25.32.1 Business Overview
25.32.2 Product Offerings
25.33 Swiss Precision Diagnostics
25.33.1 Business Overview
25.33.2 Product Offerings
25.34 Thermo Fisher Scientific
25.34.1 Business Overview
25.34.2 Product Offerings
25.35 Trinity Biotech
25.35.1 Business Overview
25.35.2 Product Offerings
25.36 Xiamen Biotime BiotechnOlogy
25.36.1 Business Overview
25.36.2 Product Offerings
25.37 Zhejiang Orient Gene Biotech
25.37.1 Business Overview
25.37.2 Product Offerings
26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations
27 Quantitative Summary
27.1 Market By Geography
27.2 Market By Product
27.3 Product By Prescription
27.4 Market By Applications
27.5 Market By End-Users
28 Appendix
28.1 Abbreviations
List Of Exhibits
Exhibit 1 Segmentation of Global Rapid Diagnostics Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Advantages of Rapid Diagnostic Tests
Exhibit 4 Laboratory and Rapid Tests Performed in Various Healthcare Settings
Exhibit 5 Impact of Increase in Demand for the Rapid Tests Due to COVID-19
Exhibit 6 Top Four Countries with the Highest Number of COVID-19 Cases Globally, as of 28-09-2020
Exhibit 7 Impact of Growing Demand for Rapid Molecular Diagnostic Tests
Exhibit 8 Impact of New Rapid Diagnostics’ Product Approvals/Launches
Exhibit 9 Impact of Growing Prevalence/Incidence of Several Acute & Chronic Diseases
Exhibit 10 Global Diabetes Prevalence 2017-20245 (million)
Exhibit 11 Number of People with HIV/AIDS 2019 (million)
Exhibit 12 Impact of Preference for Early Diagnosis & Disease Prevention
Exhibit 13 Advantages of Early Diagnosis & Disease Prevention
Exhibit 14 Impact of Focus on Innovative Rapid Diagnostic Platforms
Exhibit 15 Impact of Stringent Regulations Coupled with Product Recalls
Exhibit 16 Impact of Limitations and Data Accuracy Challenges with Rapid Diagnostics
Exhibit 17 Major Limitations of Rapid Diagnostic Tests
Exhibit 18 Common Errors in POC Diagnostic Tests
Exhibit 19 Global Rapid Diagnostic Market by Product
Exhibit 20 Global Rapid Diagnostic Market by Application
Exhibit 21 Global Rapid Diagnostic Market by Prescription
Exhibit 22 Global Rapid Diagnostic Market by End-User
Exhibit 23 Global Rapid Diagnostic Market by Geography
Exhibit 24 Global Rapid Diagnostics Market 2019–2025 ($ billion)
Exhibit 25 Five Forces Analysis 2019
Exhibit 26 Incremental Growth by Segment 2019 & 2025
Exhibit 27 Global Testing Market by Product
Exhibit 28 Global Rapid Testing Market by Product: Incremental Growth
Exhibit 29 Global Rapid Testing Market by Product: Absolute Growth
Exhibit 30 Global Rapid Testing Market by Consumables: Incremental Growth Versus Absolute Growth
Exhibit 31 Global Rapid Testing Market – Consumables 2019–2025 ($Billion)
Exhibit 32 Global Rapid Testing Market by Instruments/ Analyzers: Incremental Growth Versus Absolute Growth
Exhibit 33 Global Rapid Testing Instruments and Analyzers Market 2019–2025 ($ Billion)
Exhibit 34 Incremental Growth by Application 2019 & 2025
Exhibit 35 Global Rapid Diagnostics Market by Applications
Exhibit 36 Global Rapid Diagnostics Market by Applications: Incremental Growth
Exhibit 37 Global Rapid Diagnostics Market by Applications: Absolute Growth
Exhibit 38 Global Rapid Diagnostics Market by Applications - Blood Glucose Testing: Incremental Growth Versus Absolute Growth
Exhibit 39 Global Rapid Blood Glucose Testing Diagnostics Market 2019–2025 ($ billion)
Exhibit 40 Global Rapid Diagnostics Market by Applications – Cardiovascular and Metabolic Testing: Incremental Growth Versus Absolute Growth
Exhibit 41 Global Rapid Diagnostics CardioMetabolic Testing Market 2019–2025 ($ Billion)
Exhibit 42 Global Rapid Diagnostics Market by Applications – Infectious Disease: Incremental Growth Versus Absolute Growth
Exhibit 43 Global Rapid Diagnostics Infectious Disease Testing Market 2019–2025 ($ Billion)
Exhibit 44 Staff Time Spent on Testing and Prescribing VKAs (Minutes/day) Before and After POCT Use
Exhibit 45 Global Rapid Diagnostics Market by Applications –Blood Coagulation Rapid Testing: Incremental Growth Versus Absolute Growth
Exhibit 46 Global Rapid Blood Coagulation Testing Market 2019–2025 ($ Billion)
Exhibit 47 Global Rapid Diagnostics Market by Applications - Hematology Testing: Incremental Growth Versus Absolute Growth
Exhibit 48 Global Rapid Hematology Testing Market 2019–2025 ($ Billion)
Exhibit 49 Global Rapid Diagnostics Market by Applications – Rapid Cancer Testing: Incremental Growth Versus Absolute Growth
Exhibit 50 Global Rapid Cancer Testing Diagnostics Market 2019–2025 ($ billion)
Exhibit 51 Comparison of Rapid & Lab-Based Drug Screening in Urine Samples Based on Turnaround Time (Minutes)
Exhibit 52 Global Rapid Diagnostics Market by Applications – Rapid Drugs of Abuse Testing: Incremental Growth Versus Absolute Growth
Exhibit 53 Global Rapid Drug of Abuse Testing 2019–2025 ($ billion)
Exhibit 54 Global Rapid Diagnostics Market by Applications - Pregnancy & Fertility/ Ovulation Testing: Incremental Growth Versus Absolute Growth
Exhibit 55 Global Rapid Diagnostics Pregnancy & Fertility/ Ovulation Market 2019–2025 ($ Billion)
Exhibit 56 Incremental Growth by Segment 2019 & 2025
Exhibit 57 Global Rapid Testing Market by Prescription
Exhibit 58 Global Rapid Diagnostics Market by Prescription: Incremental Growth
Exhibit 59 Global Rapid Diagnostics Market by Prescription: Absolute Growth
Exhibit 60 Global Rapid Diagnostics Market by Professional POC Diagnostics: Incremental Growth Versus Absolute Growth
Exhibit 61 Global Rapid Professional Rapid Testing Market 2019–2025 ($ Billion)
Exhibit 62 Global Rapid Diagnostics Market by Home/OTC-Based Rapid Diagnostics: Incremental Growth Versus Absolute Growth
Exhibit 63 Global Rapid Home/OTC-Based Rapid Diagnostics Market 2019–2025 ($ Billion)
Exhibit 64 Incremental Growth by End-User 2019 & 2025
Exhibit 65 Global Rapid Diagnostics Market by End-User
Exhibit 66 Global Rapid Testing Market by End-Users: Incremental Growth
Exhibit 67 Global Rapid Testing Market by End-Users: Absolute Growth
Exhibit 68 Comparison of Time Used in the Emergency Departments (minutes)
Exhibit 69 Global Rapid Testing Market by End-Users – Hospitals and Clinics: Incremental Growth Versus Absolute Growth
Exhibit 70 Global Rapid Testing Hospitals & Clinics Market 2019–2025 ($ Billion)
Exhibit 71 Global Rapid Testing Market by End-users – Laboratories: Incremental Growth Versus Absolute Growth
Exhibit 72 Global Rapid Testing Laboratories Market 2019–2025 ($ Billion)
Exhibit 73 Global Rapid Testing Market by End-Users – Home Care: Incremental Growth Versus Absolute Growth
Exhibit 74 Global Rapid Testing Home Care Market 2019–2025 ($ Billion)
Exhibit 75 Global Rapid Testing Market by End-Users – Others: Incremental Growth Versus Absolute Growth
Exhibit 76 Global Rapid Testing Others Market 2019–2025 ($ Billion)
Exhibit 77 Incremental Growth by Geography 2019 & 2025
Exhibit 78 Global Rapid Diagnostics Market by Geography
Exhibit 79 Global Rapid Testing Market by Geography: Incremental Growth
Exhibit 80 Global Rapid Testing Market by Geography: Absolute Growth
Exhibit 81 Global Rapid Testing Market in North America: Incremental Growth Versus Absolute Growth
Exhibit 82 Rapid Diagnostics Market – North America
Exhibit 83 Rapid Testing Market in North America 2019–2025 ($ Billion)
Exhibit 84 Incremental Growth in North America 2019 & 2025
Exhibit 85 Rapid Diagnostics Market in US 2019–2025 ($ Billion)
Exhibit 86 Rapid Diagnostics Market in Canada 2019–2025 ($ Billion)
Exhibit 87 Rapid Diagnostics Market in Europe: Incremental Growth Versus Absolute Growth
Exhibit 88 Rapid Diagnostics Market in Europe 2019–2025 ($ Billion)
Exhibit 89 Incremental Growth in Europe 2019 & 2025
Exhibit 90 Rapid Diagnostics Market in Germany 2019–2025 ($ Billion)
Exhibit 91 Rapid Diagnostics Market in France 2019–2025 ($ Billion)
Exhibit 92 Rapid Diagnostics Market in UK 2019–2025 ($ Billion)
Exhibit 93 Rapid Diagnostics Market in Italy 2019–2025 ($ Billion)
Exhibit 94 Rapid Diagnostics Market in Spain 2019–2025 ($ Billion)
Exhibit 95 Global Rapid Testing Market APAC: Incremental Growth Versus Absolute Growth
Exhibit 96 Rapid Diagnostics Market in APAC 2019–2025 ($ Billion)
Exhibit 97 Incremental Growth in APAC 2019 & 2025
Exhibit 98 Rapid Diagnostics Market in China 2019–2025 ($ Billion)
Exhibit 99 Rapid Diagnostics Market in Japan 2019–2025 ($ billion)
Exhibit 100 Rapid Diagnostics Market in Australia 2019–2025 ($ billion)
Exhibit 101 Rapid Diagnostics Market in South Korea 2019–2025 ($ Billion)
Exhibit 102 Rapid Diagnostics Market in India 2019–2025 ($ Billion)
Exhibit 103 Rapid Diagnostics Market in Latin America 2019 (Billion)
Exhibit 104 Rapid Diagnostics Market in Latin America: Incremental Growth Versus Absolute Growth
Exhibit 105 Rapid Diagnostics Market in Latin America 2019–2025 ($ Billion)
Exhibit 106 Incremental Growth in Latin America 2019 & 2025
Exhibit 107 Rapid Diagnostics Market in Brazil 2019–2025 ($ Billion)
Exhibit 108 Rapid Diagnostics Market in Mexico 2019–2025 ($ Billion)
Exhibit 109 Rapid Diagnostics Market in Argentina 2019–2025 ($ Billion)
Exhibit 110 Global Rapid Testing Market Middle East and Africa: Incremental Growth Versus Absolute Growth
Exhibit 111 Rapid Diagnostics in the Middle East and Africa – (Billion)
Exhibit 112 Rapid Diagnostics Market in Middle East & Africa 2019–2025 ($ billion)
Exhibit 113 Incremental Growth in Middle East and Africa 2019 & 2025
Exhibit 114 Rapid Diagnostics Market in Turkey 2019–2025 ($ Billion)
Exhibit 115 Rapid Diagnostics Market in South Africa 2019–2025 ($billion)
Exhibit 116 Rapid Diagnostics Market in Saudi Arabia 2019–2025 ($ billion)
Exhibit 117 Abbott: Sales Breakdown by Segments in 2018−2019 ($ million)
Exhibit 118 Abbott: Net Sales 2017−2019 ($ million)
Exhibit 119 Abbott: Net Sales breakdown by Diagnostics Product Segment 2018−2019 ($ million)
Exhibit 120 F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($ billion)
Exhibit 121 F. Hoffmann-La Roche: Revenue by Geographies 2019 (%)
Exhibit 122 Quidel: Revenue 2017−2019 ($ million)
Exhibit 123 Quidel: Research and Development Expenses 2017−2019 ($ million)
Exhibit 124 Danaher: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 125 Danaher: Net Sales 2017−2019 ($ million)
Exhibit 126 Danaher: Revenue by Geography 2019
Exhibit 127 Danaher: R&D Expenditure 2017−2019 ($ million)
Exhibit 128 Danaher: Diagnostics Segment Sales 2017−2019 ($ million)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 Recent Product Launches in the Rapid Diagnostics Market
Table 4 Popular Innovative Rapid Diagnostic Analyzers
Table 5 Product Recalls in Rapid Diagnostics Market
Table 6 Importance of Drug Detection
Table 7 Abbott: Major Product Offerings
Table 8 F. Hoffmann-La Roche: Major Product Offerings
Table 9 Siemens Healthineers: Major Product Offerings
Table 10 Ascensia Diabetes Care Holdings: Major Product Offerings
Table 11 LifeScan: Major Product Offerings
Table 12 BD: Major Product Offerings
Table 13 Quidel: Major Product Offerings
Table 14 Danaher: Major Product Offerings
Table 15 Abaxis: Major Product Offerings
Table 16 Abingdon Health: Major Product Offerings
Table 17 ACON Laboratories: Major Product Offerings
Table 18 AgaMatrix: Major Product Offerings
Table 19 Arbor Vita: Major Product Offerings
Table 20 Assure Tech: Major Product Offerings
Table 21 Autobio: Major Product Offerings
Table 22 Beijing Wantai Biopharma: Major Product Offerings
Table 23 BioMedomics: Major Product Offerings
Table 24 Biomerica: Major Product Offerings
Table 25 bioMérieux: Major Product Offerings
Table 26 Biopanda Reagents: Major Product Offerings
Table 27 Chembio Diagnostic Systems: Major Product Offerings
Table 28 Cellex: Major Product Offerings
Table 29 Clinical Reference Laboratory: Major Product Offerings
Table 30 CTK Biotech: Major Product Offerings
Table 31 EKF Diagnostics: Major Product Offerings
Table 32 Exact Sciences: Major Product Offerings
Table 33 Hangzhou AllTest Biotech: Major Product Offerings
Table 34 Hangzhou Biotest Biotech: Major Product Offerings
Table 35 Healgen Scientific: Major Product Offerings
Table 36 Instrumentation Laboratory: Major Product Offerings
Table 37 Megna Health: Major Product Offerings
Table 38 Meridian Bioscience: Major Product Offerings
Table 39 MP Biomedicals: Major Product Offerings
Table 40 NOWDiagnostics: Major Product Offerings
Table 41 Salofa Oy: Major Product Offerings
Table 42 Sekisui Diagnostics: Major Product Offerings
Table 43 SEASUN BIOMATERIALS: Major Product Offerings
Table 44 Sinocare: Major Product Offerings
Table 45 SunScreen Diagnostics: Major Product Offerings
Table 46 Sysmex: Major Product Offerings
Table 47 Swiss Precision Diagnostics: Major Product Offerings
Table 48 Thermo Fisher Scientific: Major Product Offerings
Table 49 Trinity Biotech: Major Product Offerings
Table 50 Xiamen Biotime Biotechnology: Major Product Offerings
Table 51 Zhejiang Orient Gene Biotech: Major Product Offerings
Table 52 Global Rapid Diagnostics Market by Geography 2019−2025 ($ Billion)
Table 53 Global Rapid Diagnostics Market by Geography 2019−2025 (%)
Table 54 Global Rapid Diagnostics Market by Product 2019−2025 (& billion)
Table 55 Global Rapid Diagnostics Market by Product 2019−2025 (%)
Table 56 Global Rapid Diagnostics Market by Prescription 2019−2025 ($ billion)
Table 57 Global Rapid Diagnostics Market by Prescription 2019−2025 (%)
Table 58 Global Rapid Diagnostics Market by Application 2019−2025 ($ billion)
Table 59 Global Rapid Testing Market by Applications 2019−2025 ($ billion)
Table 60 Global Rapid Diagnostics Market by End-Users 2019−2025 ($ billion)
Table 61 Global Rapid Diagnostics Market by End-Users 2019−2025 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
